| Product Code: ETC7623006 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import of aldosterone receptor antagonists to Ireland experienced significant growth in 2024, with top exporting countries being Germany, UK, USA, Canada, and other areas. The market concentration, as measured by HHI, increased from moderate to high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 23.28%, with a remarkable growth spurt of 68.55% from 2023 to 2024. This data suggests a growing demand for aldosterone receptor antagonists in Ireland, with key supply sources diversifying and intensifying.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Aldosterone Receptor Antagonists Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Aldosterone Receptor Antagonists Market - Industry Life Cycle |
3.4 Ireland Aldosterone Receptor Antagonists Market - Porter's Five Forces |
3.5 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume Share, By Dosage Form, 2022 & 2032F |
3.7 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume Share, By Indication, 2022 & 2032F |
3.8 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Ireland Aldosterone Receptor Antagonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in Ireland |
4.2.2 Growing awareness about the benefits of aldosterone receptor antagonists in managing heart conditions |
4.2.3 Favorable government initiatives and healthcare policies promoting the use of advanced cardiovascular drugs |
4.3 Market Restraints |
4.3.1 High cost associated with aldosterone receptor antagonists leading to limited affordability for some patients |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
4.3.3 Potential side effects and safety concerns associated with aldosterone receptor antagonists |
5 Ireland Aldosterone Receptor Antagonists Market Trends |
6 Ireland Aldosterone Receptor Antagonists Market, By Types |
6.1 Ireland Aldosterone Receptor Antagonists Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Steroidal Mineralocorticoid Receptor Antagonists, 2022 - 2032F |
6.1.4 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Non-steroidal Mineralocorticoid Receptor Antagonists, 2022 - 2032F |
6.2 Ireland Aldosterone Receptor Antagonists Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Tablets, 2022 - 2032F |
6.2.3 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Suspensions, 2022 - 2032F |
6.2.4 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Capsules, 2022 - 2032F |
6.2.5 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Creams & Gels, 2022 - 2032F |
6.3 Ireland Aldosterone Receptor Antagonists Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Hypertension, 2022 - 2032F |
6.3.3 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Heart Failure, 2022 - 2032F |
6.3.4 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Edema, 2022 - 2032F |
6.3.5 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Primary Aldosteronism, 2022 - 2032F |
6.3.6 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Others, 2022 - 2032F |
6.4 Ireland Aldosterone Receptor Antagonists Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Hospital Pharmacies, 2022 - 2032F |
6.4.3 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Online Pharmacies, 2022 - 2032F |
6.4.4 Ireland Aldosterone Receptor Antagonists Market Revenues & Volume, By Retail Pharmacies, 2022 - 2032F |
7 Ireland Aldosterone Receptor Antagonists Market Import-Export Trade Statistics |
7.1 Ireland Aldosterone Receptor Antagonists Market Export to Major Countries |
7.2 Ireland Aldosterone Receptor Antagonists Market Imports from Major Countries |
8 Ireland Aldosterone Receptor Antagonists Market Key Performance Indicators |
8.1 Number of prescriptions for aldosterone receptor antagonists per quarter |
8.2 Percentage of cardiologists recommending aldosterone receptor antagonists as a treatment option |
8.3 Patient adherence rates to aldosterone receptor antagonist therapy |
9 Ireland Aldosterone Receptor Antagonists Market - Opportunity Assessment |
9.1 Ireland Aldosterone Receptor Antagonists Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Ireland Aldosterone Receptor Antagonists Market Opportunity Assessment, By Dosage Form, 2022 & 2032F |
9.3 Ireland Aldosterone Receptor Antagonists Market Opportunity Assessment, By Indication, 2022 & 2032F |
9.4 Ireland Aldosterone Receptor Antagonists Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Ireland Aldosterone Receptor Antagonists Market - Competitive Landscape |
10.1 Ireland Aldosterone Receptor Antagonists Market Revenue Share, By Companies, 2025 |
10.2 Ireland Aldosterone Receptor Antagonists Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here